Why It Is Crucial that CMOs, Suppliers, and Biologic Manufacturers Work Closely Together

The collaboration between biologics manufacturers and medical device supplier partners will be examined during an afternoon session at Pharmapack, “Challenges in packaging & devices development: biologics, materials, sustainability and quality consistency.” Lionel Jeannin, fellow, global packaging & device development, Novartis Pharma AG, will be co-chairing the session along with Dr. Joel Richard, senior vice president, peptides, CMC & engineering, IPSEN. MD+DI asked Jeannin a few questions about such industry collaboration and the upcoming session.   MD+DI: The session description describes “collaboration with external partners like CMOs, suppliers and service providers.” Are there any challenges in such collaboration, and how can they be overcome? Jeannin: The session will start with a presentation from colleagues of mine regarding key factors for successful collaboration with external partners when developing new packaging system for biologics. The challenges in that field are numerous and include the need for suppliers to have a thorough understanding of biologics and their specific sensitivity to potential contaminants such as substances that can leach from the packaging materials or can be derived from any additives used in their processing. As a consequence, there is a need for a tight control and assessment of any changes made to the raw materials composition and processing, as well as to secure the long-term supply of specific raw material grade...
Source: MDDI - Category: Medical Devices Authors: Tags: Contract Manufacturing Source Type: news